Denali Therapeutics shares owned by Bnp Paribas Investment Partners
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Bnp Paribas Investment Partners
from 13F filings
Historical chart of Bnp Paribas Investment Partners investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Bnp Paribas Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Bnp Paribas Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $4.9M | 299k | 16.51 |
| 2025-09-30 | $18k | 1.3k | 14.16 |
| 2025-06-30 | $16k | 1.1k | 14.05 |
More positions owned by Bnp Paribas Investment Partners
View all positions for Bnp Paribas Investment Partners